Gene · 3015
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bromodomain protein IBD1 bridges histone acetylation and H2A.Z deposition to fine-tune transcription. | Nucleic Acids Res | 2026 | 41728948 | PubTator, text mining | PubMed |
| The role of epigenetic modifications in hematological cancers. | Front Oncol | 2026 | 41727658 | PubTator, text mining | PubMed |
| Deficient de-S-acylation in aging and CLN1 contributes to lyso-mitochondrial dysfunction, lipid dyshomeostasis, and resultant lipofuscin biogenesis. | Res Sq | 2026 | 41727595 | PubTator, text mining | PubMed |
| A Proteoform-Resolved Atlas of Human Cardiac Histones. | Res Sq | 2026 | 41727594 | PubTator, text mining | PubMed |
| Structural insights into specific recognition of the histone variant H2A.Z by the YL1 subunit of SRCAP chromatin-remodeling complex. | J Biol Chem | 2026 | 41708003 | PubTator, text mining | PubMed |
| A systematic guide for identifying transcription factors that directly regulate the expression of a gene of interest. | Genome Res | 2026 | 41702709 | PubTator, text mining | PubMed |
| Correction to "The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53-binding site of the p21 gene in response to doxorubicin". | FEBS J | 2026 | 41671065 | PubTator, text mining | PubMed |
| Cooperative and Opposing Functions of ANP32E and VPS72 Govern Gene Promoter Chromatin Status. | Res Sq | 2026 | 41646306 | PubTator, text mining | PubMed |
| Chromatin remodeler Fun30 facilitates the relocation of persistent DNA double-strand breaks to the nuclear periphery. | FEBS Lett | 2026 | 41630098 | PubTator, text mining | PubMed |
| Beyond bacterial defences: the role of lysozyme in cancer. | Clin Transl Med | 2026 | 41622693 | PubTator, text mining | PubMed |
| Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. | J Immunother Cancer | 2026 | 41617396 | PubTator, text mining | PubMed |
| Histone Variant H2A.Z Enhances Histone and Nucleosome Dynamics. | Mol Cell Proteomics | 2026 | 41617136 | PubTator, text mining | PubMed |
| Advances in scCUT&Tag and computational analysis for single-cell gene regulatory element mapping. | Brief Bioinform | 2026 | 41609358 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| Single amino-acid differences define H2B variants and modify chromatin accessibility to induce EMT in breast cancer. | Oncogene | 2026 | 41580505 | PubTator, text mining | PubMed |
| (Re)defining the human chromatome: an integrated meta-analysis of localization, function, abundance, physical properties, and domain composition of chromatin proteins. | Nucleic Acids Res | 2026 | 41533575 | PubTator, text mining | PubMed |
| ExoSloNano: multimodal nanogold labels for identification of macromolecules in live cells and cryo-electron tomograms. | Nat Methods | 2026 | 41315814 | PubTator, text mining | PubMed |
| Skin Epidermal Progenitor Maintenance by the SRCAP-H2A.Z Axis Downstream to Extracellular Signal-Regulated Kinase and mTOR Signaling. | J Invest Dermatol | 2026 | 40812470 | PubTator, text mining | PubMed |
| Srcap Chromatin Remodeler Is Required for Efficient Replication Dynamics in Mammalian Cells. | Int J Mol Sci | 2025 | 41465613 | PubTator, text mining | PubMed |
| Direct recruitment of TONSOKU by the N-terminal tails of histone variants H2A.X and H2A.W coordinates DNA repair. | Sci Adv | 2025 | 41406205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3015/papers?page=3